Healthcare -
Biotechnology - NASDAQ - US
$ 7.48
2.89 %
$ 511 M
Market Cap
-3.76
P/E
EYPT - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities EYPT - EyePoint Pharmaceuticals, Inc.
187 M
LAST VALUE
-7.13%
2 YEAR CAGR
25.26%
5 YEAR CAGR
44.64%
10 YEAR CAGR